Essex Woodlands Health Ventures as of March 31, 2017
Portfolio Holdings for Essex Woodlands Health Ventures
Essex Woodlands Health Ventures holds 10 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Abiomed | 41.4 | $182M | 1.5M | 125.20 | |
| Revance Therapeutics (RVNC) | 21.8 | $96M | 4.6M | 20.80 | |
| Axogen (AXGN) | 11.6 | $51M | 4.9M | 10.45 | |
| Entellus Medical Cm | 10.2 | $45M | 3.2M | 13.80 | |
| Corium Intl | 8.9 | $39M | 9.4M | 4.18 | |
| Endologix | 3.3 | $15M | 1.3M | 11.52 | |
| MediciNova (MNOV) | 1.6 | $7.0M | 1.2M | 5.99 | |
| Ligand Pharmaceuticals In (LGND) | 0.8 | $3.3M | 31k | 105.85 | |
| Acura Pharmaceuticals (ACUR) | 0.3 | $1.2M | 2.0M | 0.60 | |
| Catalyst Biosciences | 0.2 | $757k | 79k | 9.63 |
